Skip to main content
Funded Studies

Omar S. Mabrouk, PhD

Research Investigator at University of Michigan

Location: Ann Arbor, MI United States

Omar S. Mabrouk, PhD, is an extensively trained neuropharmacologist with experience both in academia and the pharmaceutical industry. He has over a decade of research experience investigating the neurobiological basis of diseases like Parkinson’s disease. He has a deep understanding of basal ganglia circuitry and a strong commitment to the development of novel therapeutics for Parkinson’s disease and levodopa-induced dyskinesia. Dr. Mabrouk develops innovative techniques to sample and analyze brain chemistry with microdialysis and mass spectrometry. He applies these tools to provide a better understanding of these diseases and potential therapeutics.

Dr. Mabrouk has more than 25 peer-reviewed publications to date, including a book chapter outlining the use of advanced microdialysis and mass spectrometry to measure neuropeptide concentrations in vivo. For his efforts, Dr. Mabrouk was promoted to research investigator, a research faculty position at the University of Michigan.

Dr. Mabrouk is also recipient of a 2013 Dyskinesia Challenge grant award from The Michael J. Fox Foundation to assess the effects of oxytocin on levodopa-induced dyskinesia. Finally, Dr. Mabrouk is co-investigator on a R01 grant from the National Heart, Lung and Blood Institute to look at the effects of blood-brain barrier function in Parkinson’s disease.

Associated Grants

  • Analysis of Brain and Peripheral Small Molecule Levels in Parkinson’s Disease


  • Oxytocin Effects on Levodopa-induced Dyskinesias


We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.